Figure 1

Tiziana Life Sciences Plc

Decrease in PET signal after foralumab treatment (bottom row) as compared to pre-treatment baseline (top-row). Adapted from Singhal T et al. Clinical Nuclear Medicine 2025 (in press).

Format

JPEG

Quelle:

Tiziana Life Sciences Ltd.

Downloads